06:47:52 Europe / Stockholm

Attachments

Share price & Turnover

Share price change and turnover during the day of this press release

Calendar

2025-05-22 Annual General meeting
2025-05-09 Quarterly Report 2025-Q1
2025-02-21 Year-end Report 2024
2024-11-08 Quarterly Report 2024-Q3
2024-08-16 Quarterly Report 2024-Q2
2024-05-23 Ex-date Ordinary Dividend RAY B 0.70 SEK
2024-05-23 Ex-date Bonus Dividend RAY B 1.3
2024-05-22 Annual General meeting
2024-05-17 Quarterly Report 2024-Q1
2024-02-23 Year-end Report 2023
2023-11-17 Quarterly Report 2023-Q3
2023-08-25 Quarterly Report 2023-Q2
2023-05-26 Ex-date Ordinary Dividend RAY B 0.00 SEK
2023-05-25 Annual General meeting
2023-05-17 Quarterly Report 2023-Q1
2023-02-28 Year-end Report 2022
2022-11-29 Quarterly Report 2022-Q3
2022-08-29 Quarterly Report 2022-Q2
2022-05-27 Ex-date Ordinary Dividend RAY B 0.00 SEK
2022-05-25 Annual General meeting
2022-05-18 Quarterly Report 2022-Q1
2022-02-23 Year-end Report 2021
2021-11-18 Quarterly Report 2021-Q3
2021-08-25 Quarterly Report 2021-Q2
2021-05-27 Ex-date Ordinary Dividend RAY B 0.00 SEK
2021-05-26 Annual General meeting
2021-05-05 Quarterly Report 2021-Q1
2021-02-23 Year-end Report 2020
2020-11-18 Quarterly Report 2020-Q3
2020-08-26 Quarterly Report 2020-Q2
2020-07-01 Ex-date Ordinary Dividend RAY B 0.00 SEK
2020-06-30 Annual General meeting
2020-05-05 Quarterly Report 2020-Q1
2020-02-14 Year-end Report 2019
2019-11-14 Quarterly Report 2019-Q3
2019-08-20 Quarterly Report 2019-Q2
2019-05-22 Ex-date Ordinary Dividend RAY B 0.00 SEK
2019-05-21 Annual General meeting
2019-05-09 Quarterly Report 2019-Q1
2019-02-20 Year-end Report 2018
2018-11-15 Quarterly Report 2018-Q3
2018-08-23 Quarterly Report 2018-Q2
2018-05-31 Ex-date Ordinary Dividend RAY B 0.00 SEK
2018-05-29 Annual General meeting
2018-05-09 Quarterly Report 2018-Q1
2018-02-15 Year-end Report 2017
2017-11-22 Quarterly Report 2017-Q3
2017-08-24 Quarterly Report 2017-Q2
2017-05-24 Ex-date Ordinary Dividend RAY B 0.00 SEK
2017-05-23 Annual General meeting
2017-05-19 Quarterly Report 2017-Q1
2017-02-17 Year-end Report 2016
2016-11-18 Quarterly Report 2016-Q3
2016-08-25 Quarterly Report 2016-Q2
2016-05-18 Ex-date Ordinary Dividend RAY B 0.25 SEK
2016-05-17 Annual General meeting
2016-05-12 Quarterly Report 2016-Q1
2016-02-18 Year-end Report 2015
2015-11-25 Quarterly Report 2015-Q3
2015-08-28 Quarterly Report 2015-Q2
2015-05-29 Ex-date Ordinary Dividend RAY B 0.00 SEK
2015-05-28 Annual General meeting
2015-05-08 Quarterly Report 2015-Q1
2015-02-12 Year-end Report 2014
2014-11-27 Quarterly Report 2014-Q3
2014-08-27 Quarterly Report 2014-Q2
2014-05-28 Ex-date Ordinary Dividend RAY B 0.00 SEK
2014-05-27 Annual General meeting
2014-05-16 Quarterly Report 2014-Q1
2014-02-13 Year-end Report 2013
2013-11-27 Quarterly Report 2013-Q3
2013-08-28 Quarterly Report 2013-Q2
2013-05-23 Ex-date Ordinary Dividend RAY B 0.00 SEK
2013-05-22 Annual General meeting
2013-05-16 Quarterly Report 2013-Q1
2013-02-14 Year-end Report 2012
2012-11-16 Quarterly Report 2012-Q3
2012-08-28 Quarterly Report 2012-Q2
2012-05-31 Ex-date Ordinary Dividend RAY B 0.00 SEK
2012-05-30 Annual General meeting
2012-05-23 Quarterly Report 2012-Q1
2012-02-16 Year-end Report 2011
2011-11-24 Quarterly Report 2011-Q3
2011-05-26 Ex-date Ordinary Dividend RAY B 0.50 SEK
2011-05-25 Annual General meeting
2011-05-04 Quarterly Report 2011-Q1
2011-02-18 Year-end Report 2010
2010-11-12 Quarterly Report 2010-Q3
2010-08-27 Quarterly Report 2010-Q2
2010-05-26 Ex-date Ordinary Dividend RAY B 0.50 SEK
2010-05-25 Annual General meeting
2010-05-11 Quarterly Report 2010-Q1
2009-11-20 Quarterly Report 2009-Q3
2009-08-27 Quarterly Report 2009-Q2
2009-05-27 Ex-date Ordinary Dividend RAY B 0.00 SEK
2009-05-26 Annual General meeting
2009-05-15 Quarterly Report 2009-Q1
2008-06-25 Split RAY B 1:3
2003-06-10 Split RAY B 20:1

Description

CountrySweden
ListMid Cap Stockholm
SectorHealth care
IndustryMedical technology
RaySearch Laboratories är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av mjukvarulösningar för sjukvårdsindustrin. Bolagets produkter används främst inom behandling av cancer och andra allvarliga sjukdomar, och vidaresäljs som dosplanerings- respektive informationssystem. Olika funktioner inkluderar maskininlärning, beräkningshastighet, automatiserad planering, virtuell simulering, adaptiv terapi och digitala arbetsflöden. Produkterna används av ett flertal kliniker.
2023-07-07 16:00:00

Henrik Bergentoft has decided to leave the position as CFO of RaySearch Laboratories AB (publ) for new challenges. Annika Blondeau Henriksson has been appointed interim CFO and she will also be part of the senior management team. Henrik will remain in a supporting role during his notice period.

Recruitment of a permanent CFO will begin immediately. Annika will remain as interim CFO until this person is in place.

Henrik Bergentoft: "I wish RaySearch good luck and success with its important mission in the fight against cancer. For me, an orderly handover to Annika remains."

Johan Löf, founder and CEO, RaySearch: "Henrik Bergentoft has done a good job during his short time at RaySearch and we wish him the best of luck in his continued career. With Annika Blondeau Henriksson assuming the role of interim CFO with immediate effect, we will have a competent professional ensuring our financial department's capacity while the recruitment of a successor is underway."